Stephen Keleher, an officer of Radian Group Inc, filed a Form 144 notice of proposed sale of 8,000 shares of common stock on November 5, 2026, through Fidelity Brokerage Services LLC on the NYSE.
Kearny Financial Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting net income of $10.044 million for the three months ended September 30, 2026.
Ormat Technologies, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three and nine months ended September 30, 2026, as reported under NYSE:ORA.
Brendan M. Foley, Chairman, President and Chief Executive Officer of McCormick & Co Inc, filed a statement of changes in beneficial ownership on November 5, 2026, covering transactions dated October 26 through November 3, 2026.
Saffron & Hive LLC filed a Schedule 13G with the SEC on November 5, 2026, disclosing a beneficial ownership position of 298,760 ordinary shares of Rail Vision Ltd., representing 13.0% of the company's outstanding ordinary shares as of the event date of November 3, …
Mark J. Parrell, a former officer and director of VivMark Residential, filed a Form 144 notice on November 5, 2026, disclosing a proposed sale of common shares on the New York Stock Exchange.
Director Ned S. Holmes of Prosperity Bancshares Inc filed a Form 4 on November 5, 2026, disclosing sales of common stock totaling 1,100 shares executed on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.
Camden National Corporation filed its Form 10-Q with the SEC on November 5, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, on NASDAQ:CAC.
Enviri Corporation filed a Form 10-Q with the SEC for the quarterly period ended September 30, 2026, its first quarterly report as a separately traded public company following the completion of a spin-off and merger transaction on June 1, 2026.
Edward Hallen, an officer and director of Klaviyo, Inc., filed a Form 144 notice on November 5, 2026, proposing to sell 98,782 shares of Klaviyo Series A stock on the NYSE with an aggregate market value of $2,005,274.60.